cbdMD Schedules Q3 Earnings Call Amid Expanding Product Portfolio

  • cbdMD to host Q3 earnings call on August 13, 2026, at 4:20 PM ET.
  • Results cover period ending June 30, 2026.
  • Company operates multiple brands including Paw CBD, ATRx, and Herbal Oasis.
  • Products range from THC-free CBD to Delta 9 compliant items.

cbdMD's earnings call comes as the CBD and cannabis sectors face increasing regulatory scrutiny and competitive pressures. The company's diversification into pet products, functional mushrooms, and THC-infused beverages reflects broader industry trends toward product innovation and market segmentation. Investors will be watching for signs of revenue stability amid shifting consumer preferences.

Revenue Growth
Whether cbdMD can sustain momentum across its diversified product lines.
Regulatory Compliance
The pace at which evolving cannabis regulations impact THC-free and Delta 9 products.
Market Expansion
How Herbal Oasis' premium positioning affects cbdMD's market share in functional beverages.